These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15106085)

  • 1. Defining and assessing measles elimination goals.
    Papania MJ; Orenstein WA
    J Infect Dis; 2004 May; 189 Suppl 1():S23-6. PubMed ID: 15106085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of endemic measles transmission in Australia.
    Heywood AE; Gidding HF; Riddell MA; McIntyre PB; MacIntyre CR; Kelly HA
    Bull World Health Organ; 2009 Jan; 87(1):64-71. PubMed ID: 19197406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single endemic genotype of measles virus continuously circulating in China for at least 16 years.
    Zhang Y; Xu S; Wang H; Zhu Z; Ji Y; Liu C; Zhang X; Sun L; Zhou J; Lu P; Hu Y; Feng D; Zhang Z; Wang C; Fang X; Zheng H; Liu L; Sun X; Tang W; Wang Y; Liu Y; Gao H; Tian H; Ma J; Gu S; Wang S; Feng Y; Bo F; Liu J; Si Y; Zhou S; Ma Y; Wu S; Zhou S; Li F; Ding Z; Yang Z; Rota PA; Featherstone D; Jee Y; Bellini WJ; Xu W
    PLoS One; 2012; 7(4):e34401. PubMed ID: 22532829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles molecular epidemiology: What does it tell us and why is it important?
    Hiebert J; Severini A
    Can Commun Dis Rep; 2014 Jun; 40(12):257-260. PubMed ID: 29769849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles in the United States during the postelimination era.
    Fiebelkorn AP; Redd SB; Gallagher K; Rota PA; Rota J; Bellini W; Seward J
    J Infect Dis; 2010 Nov; 202(10):1520-8. PubMed ID: 20929352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.
    Marin M; Nguyen HQ; Langidrik JR; Edwards R; Briand K; Papania MJ; Seward JF; LeBaron CW
    Clin Infect Dis; 2006 Feb; 42(3):315-9. PubMed ID: 16392073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Zealand's COVID-19 elimination strategy.
    Baker MG; Kvalsvig A; Verrall AJ
    Med J Aust; 2020 Sep; 213(5):198-200.e1. PubMed ID: 32789868
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring progress towards the elimination of measles in Iran: supporting evidence from 2014 to 2016 by application of measles outbreaks data.
    Piri N; Karami M; Tapak L; Zahraei SM; Mohammadi Y
    BMC Public Health; 2019 Jun; 19(1):687. PubMed ID: 31159788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress towards elimination of measles in Kenya, 2003-2016.
    Kisangau N; Sergon K; Ibrahim Y; Yonga F; Langat D; Nzunza R; Borus P; Galgalo T; Lowther SA
    Pan Afr Med J; 2018; 31():65. PubMed ID: 31007812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015.
    Ramsay LC; Crowcroft NS; Thomas S; Aruffo E; Teslya A; Heffernan JM; Gournis E; Hiebert J; Jaeger V; Jiaravuthisan M; Sharron J; Severini A; Deeks SL; Gubbay J; Mazzulli T; Sander B
    Euro Surveill; 2019 Mar; 24(11):. PubMed ID: 30892178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintaining measles elimination in Canada: Moving forward.
    Lam P; Williams L; Gadient S; Squires S; St-Laurent M
    Can Commun Dis Rep; 2015 Jul; 41(7):175-178. PubMed ID: 29769949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping multiple components of malaria risk for improved targeting of elimination interventions.
    Cohen JM; Le Menach A; Pothin E; Eisele TP; Gething PW; Eckhoff PA; Moonen B; Schapira A; Smith DL
    Malar J; 2017 Nov; 16(1):459. PubMed ID: 29132357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Measles in the United States, 2001-2015.
    Clemmons NS; Wallace GS; Patel M; Gastañaduy PA
    JAMA; 2017 Oct; 318(13):1279-1281. PubMed ID: 28973240
    [No Abstract]   [Full Text] [Related]  

  • 14. Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
    Prada JM; Metcalf CJE; Takahashi S; Lessler J; Tatem AJ; Ferrari M
    Vaccine; 2017 Mar; 35(11):1488-1493. PubMed ID: 28216186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0-8 months and a control population aged 9-23 months presenting with measles-like symptoms in selected hospitals in Kaduna State.
    Olaitan AE; Ella EE; Ameh JB
    Int J Gen Med; 2015; 8():101-8. PubMed ID: 25792852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying postelimination trends for the introduction and transmissibility of measles in the United States.
    Blumberg S; Enanoria WT; Lloyd-Smith JO; Lietman TM; Porco TC
    Am J Epidemiol; 2014 Jun; 179(11):1375-82. PubMed ID: 24786800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of measles virus in Italy, 2002-2007.
    Magurano F; Fortuna C; Marchi A; Benedetti E; Bucci P; Baggieri M; Nicoletti L
    Virol J; 2012 Nov; 9():284. PubMed ID: 23173726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revealing new measles virus transmission routes by use of sequence analysis of phosphoprotein and hemagglutinin genes.
    Kessler JR; Kremer JR; Shulga SV; Tikhonova NT; Santibanez S; Mankertz A; Semeiko GV; Samoilovich EO; Tamfum JJ; Pukuta E; Muller CP
    J Clin Microbiol; 2011 Feb; 49(2):677-83. PubMed ID: 21106790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How absolute is zero? An evaluation of historical and current definitions of malaria elimination.
    Cohen JM; Moonen B; Snow RW; Smith DL
    Malar J; 2010 Jul; 9():213. PubMed ID: 20649972
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.